As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...

You can also use the company’s Prescription Discount Card ... In August 2024, Eli Lilly announced that Zepbound would be available on its online pharmacy, LillyDirect, providing a new Zepbound ...

The recent surge has been due to the tremendous growth Lilly has achieved due to its highly popular GLP-1 drugs, including ...

Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of ...

Eli Lilly's pipeline holds substantial promise, particularly with the FDA’s approval of Zepbound for Obstructive ... with a market cap of $793 billion. A discounted cash flow (DCF) analysis ...

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion. The drugmaker ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're about to lose access.

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

While much attention focuses on Lilly's incretin franchise, Mounjaro and Zepbound, the non-incretin ... redesign replaces the Part D Coverage Gap Discount Program with a new manufacturer discount ...